UPDATE : Wednesday, June 19, 2019
Gilead’s new hepatitis B therapy in controversy due to side effects
Could it be that Gilead’s new hepatitis B medicine Vemlidy (compound tenofo...
by Park Gi-taek  |  2017-05-31 17:04
Dong-A ST’s best-selling toenail fungal treatment makes home market debut
Dong-A ST has released their best-selling foot and nail fungal treatment in...
by Marian Chu  |  2017-05-31 11:52
Sanofi-Aventis Korea to launch ‘Green Santa Campaign’
Sanofi-Aventis Korea said Tuesday that it would launch a corporate social r...
by Constance Williams  |  2017-05-30 15:42
Growth of ‘pharmerging market’ to increase demand for generic drugs
The growth of emerging pharmaceutical markets, including China and India, w...
by Nam Doo-hyun  |  2017-05-29 16:27
Green Cross pushes for early FDA approval of its immunoglobulin product
The Korean pharmaceutical industry is watching with interest whether Green ...
by Lee Hye-seon  |  2017-05-25 11:01
Gilead launches new, improved hepatitis B drug
Gilead has released a new hepatitis B drug, Vemlidy (ingredient: tenofovir ...
by Marian Chu  |  2017-05-25 10:29
Hanmi ranked No. 1 in R&D investment
Hanmi Pharmaceuticals spent the largest amount of money on research and inv...
by Lee Hye-seon  |  2017-05-24 14:19
Korean drugmakers challenge Pfizer’s smoking cessation therapy Champix
Korea’s drugmakers are challenging Champix (compound: Varenicline tartrate)...
by Lee Hye-seon  |  2017-05-24 13:16
FDA approves 1st cancer drug for tumors with particular genetic feature
Merck & Co has won an accelerated approval from the U.S. Food and Drug Admi...
by Marian Chu  |  2017-05-24 12:37
Rising demand for cosmeceuticals forces pharmaceuticals to jump into cosmetics market
Domestic pharmaceutical companies are competing to jump into the cosmetics ...
by Constance Williams  |  2017-05-24 11:35
Approvals of incrementally modified drugs poured in last year
Korean pharmaceutical companies are now actively developing incrementally m...
by Lee Hye-seon  |  2017-05-23 10:55
Ildong confident of its hepatitis drug surviving market competition
Ildong Pharmaceuticals is preparing to launch its chronic hepatitis B drug,...
by Marian Chu  |  2017-05-23 10:33
Will Korea’s first stem cell therapy pass reexamination?
The pharmaceutical industry is following with interest whether Cellgram AMI...
by Nam Doo-hyun  |  2017-05-22 13:43
No more calls for drug price hikes based on inaccurate statistics: MOHW
A pharmaceutical industry group has spread distorted information by repeate...
by Nam Doo-hyun  |  2017-05-19 15:13
Celltrion launches anti-blood cancer biosimilar in Germany
Celltrion셀트리온 Inc. has launched its biosimilar to treat hematologic maligna...
by Constance Williams  |  2017-05-18 17:00
Hanmi wins approval for 1st asthma-rhinitis combination drug
Hanmi Pharmaceutical said Wednesday that the company recently won the appro...
by Constance Williams  |  2017-05-17 17:32
Young children of pharmaceutical firms’ owners have shares
Most pharmaceutical companies in Korea are run by owners’ families with the...
by Nam Doo-hyun  |  2017-05-17 17:18
Ildong Pharmaceutical develops its first new drug
The Ministry of Food and Drug Safety (MFDS) has approved Besivo Tab. (compo...
by Lee Hye-seon  |  2017-05-17 14:42
Sanofi, LG Chemical in court battle over Zemiglo
The legal battle between Sanofi-Aventis and LG Chemical over the copyright ...
by Lee Hye-seon  |  2017-05-16 16:41
P2 trial over for GemVax’s prostate disease drug
GemVax & KAEL (CEO: Kim Sang-Jae김상재) completed its phase two clinical trial...
by Marian Chu  |  2017-05-15 11:00
Back to Top